查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632592

全球脉衝电场消融市场：市场规模、份额和趋势分析（按组件、适应症、最终用途、地区和细分市场，2025-2030 年）

Pulsed Field Ablation Market Size, Share & Trends Analysis Report By Components (Catheters, Generators), By Indication (Atrial Fibrillation, Non Atrial Fibrillation), By End Use (Inpatient, Outpatient), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

脉衝电场消融市场规模与趋势：

2024 年全球脉衝电场消融市场规模估计为 9.131 亿美元，预计 2025 年至 2030 年的复合年增长率为 33.1%。

背后的原因是，它有望成为传统热消融方法更安全、更有效的替代方案。随着世界各地心房颤动（AF）盛行率的不断上升，对併发症更少、疗效更好的创新治疗方案的需求也日益增长。脉衝电场消融(PFA) 的非热机制显着降低了损伤周围组织的风险，这是射频和冷冻消融等传统消融技术的主要限制。这一独特的优势引起了医疗保健提供者和患者越来越多的兴趣，加速了其在临床实践中的应用。

心律不整，特别是心房颤动（AF），越来越普遍，影响着全世界数百万人。心房颤动的特征是心率不规则且通常很快，是最常见的持续性心律不整类型，会显着增加中风、心臟衰竭和其他严重心血管併发症的风险。随着世界人口老化以及高血压、肥胖等生活型态相关风险因子的发生率上升，心房颤动病例数也随之增加。根据强生服务公司 2024 年 2 月发表的一篇报导，全球有超过 3,750 万人患有这种疾病，凸显了其影响的广泛性。发生心房颤动的风险特别高，统计数据显示，大约四分之一的 40 岁以上的成年人在一生中的某个时刻会经历这种心律不整。盛行率的不断上升凸显了有效管理和预防策略的迫切需求。

日益加重的负担对有效、微创治疗方法产生了巨大的需求。传统治疗方法，如抗心律不整药物和导管消融，有其局限性，需要更安全、更有效的方法。因此，心律不整盛行率的不断上升是脉衝电场消融(PFA) 等先进治疗技术市场成长的主要驱动力，与传统方法相比，该技术具有更高的安全性和有效性。根据2024年2月《柳叶刀区域健康-欧洲》杂誌发表的一篇论文，心房颤动（AF）影响着1.5-2％的欧洲成年人，预计到2060年将增加到65岁及以上人群的9.5％。心房颤动是导致中风、失智症、心臟衰竭和过早死亡的重要危险因素，对老化社会和医疗保健系统构成挑战。

技术创新提高了消融手术的准确性、安全性和有效性，是 PFA 产业成长的主要驱动力。领先的医疗设备公司正在大力投资开发下一代 PFA 系统，重点是能量输送、导管设计和程序效率的改进。导管灵活性的创新以及即时成像和映射技术的整合使得消融更加有针对性和可控，从而降低了併发症的风险并改善了患者的治疗效果。 2024 年 10 月，雅培宣布在电生理学脉衝电场消融技术方面取得重大进展。该公司已完成 VOLT-AF IDE 试验的招募，评估其 Volt PFA 系统，并已启动 FOCALFLEX 试验，测试其 TactiFlex Duo 消融导管用于治疗阵发性心房颤动。这些倡议代表着雅培 PFA 导管的重大进步。

监管部门的核准对 PFA 行业来说非常重要，因为它将检验这些新设备的安全性和有效性，并为更广泛的临床应用铺平道路。近年来，多种 PFA 系统已在欧洲获得 CE 标誌，允许其在整个欧洲销售和使用。这些核准通常基于积极的临床试验结果，证明了 PFA 优于传统方法，特别是在缩短手术时间和减少併发症方面。 2024年10月，Medtronic获得FDA核准，推出搭载Sphere-9导管的Affera测绘与消融系统，用于治疗持续性心房颤动与心房扑动。这使得Medtronic成为第一家拥有两项经 FDA核准的治疗心房颤动脉衝电场消融(PFA) 技术的公司。 Sphere-9 导管凭藉其 9 毫米网格尖端提供灵活的治疗选择，并与 Pulse Select PFA 系统相辅相成，为肺静脉隔离提供单次注射解决方案。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章脉衝电场消融市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 脉衝电场消融市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章脉衝电场消融市场：按组件进行估计和趋势分析

  • 细分仪表板
  • 脉衝电场消融市场：按组件进行的变化分析
  • 脉衝电场消融市场展望（按组件）
  • 市场规模预测及趋势分析（2018-2030年）
  • 导管
  • 发电机

第 5 章脉衝电场消融市场：按适应症进行估计和趋势分析

  • 细分仪表板
  • 脉衝电场消融市场：依适应症进行变化分析
  • 脉衝电场消融市场前景（按适应症）
  • 市场规模预测及趋势分析（2018-2030年）
  • 心房颤动
  • 非心房颤动

第六章脉衝电场消融市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 脉衝电场消融市场：依最终用途进行变化分析
  • 脉衝电场消融市场前景（依最终用途）
  • 市场规模预测及趋势分析（2018-2030年）
  • 住院设施
  • 门诊设施

第 7 章脉衝电场消融市场：按地区估计和趋势分析

  • 区域控制面板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Boston Scientific Corporation
    • Abbott
    • Medtronic
    • Biosense Webster, Inc. (Johnson &Johnson Services, Inc)
    • Pulse Biosciences, Inc
    • Kardium
    • Jia Jing Electronic Co., Ltd.
    • Adagio Medical Inc
    • CardioFocus
    • Acutus Medical, Inc
Product Code: GVR-4-68040-411-3

Pulsed Field Ablation Market Size & Trends:

The global pulsed field ablation market size was estimated at USD 913.1 million in 2024 and is projected to grow at a CAGR of 33.1% from 2025 to 2030. This is driven by its promise as a safer and more effective alternative to traditional thermal ablation methods. As the global prevalence of atrial fibrillation (AF) rises, there is an increasing demand for innovative treatment options that offer fewer complications and improved outcomes. pulsed field ablation (PFA) non-thermal mechanism significantly reduces the risk of damaging surrounding tissues, a major limitation of conventional ablation techniques like radiofrequency and cryoablation. This unique advantage has led to growing interest from healthcare providers and patients, accelerating its adoption in clinical settings.

Cardiac arrhythmias, particularly atrial fibrillation (AF), are increasingly prevalent, affecting millions worldwide. AF, characterized by an irregular and often rapid heart rate, is the most common type of sustained arrhythmia, significantly raising the risk of stroke, heart failure, and other serious cardiovascular complications. As global populations age and the incidence of lifestyle-related risk factors, such as hypertension and obesity, rises, the number of AF cases continues to grow. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people globally live with this condition, emphasizing its widespread impact. The risk of developing AFib is notably high; statistics reveal that about one in four adults over the age of 40 experience this arrhythmia at some point in their lives. This growing prevalence highlights the urgent need for effective management and prevention strategies.

This escalating burden has created a substantial demand for effective, minimally invasive treatment options. Traditional therapies such as antiarrhythmic drugs and catheter-based ablation have limitations, leading to an unmet need for safer, more efficient approaches. The increasing prevalence of arrhythmias is thus a key driver of market growth for advanced treatment technologies like pulsed field ablation (PFA), which offer improved safety profiles and efficacy compared to conventional methods. In February 2024, an article in The Lancet Regional Health - Europe highlighted that atrial fibrillation (AF) affects 1.5-2% of European adults, expected to rise to 9.5% in those over 65 by 2060. AF is a significant risk factor for stroke, dementia, heart failure, and premature mortality, posing challenges for the aging population and healthcare systems.

Technological advancements are a key driver of the PFA industry's growth, as ongoing innovations enhance ablation procedures precision, safety, and efficacy. Leading medical device companies are investing heavily in the development of next-generation PFA systems, focusing on improving energy delivery, catheter design, and procedural efficiency. Innovations in catheter flexibility and the integration of real-time imaging and mapping technologies allow for more targeted and controlled ablation, reducing the risk of complications and improving patient outcomes. In October 2024, Abbott announced important advancements in its pulsed field ablation technologies for electrophysiology. The company finished enrolling participants in the VOLT-AF IDE Study aimed at evaluating the Volt PFA System and initiated the FOCALFLEX trial to test the TactiFlex Duo Ablation Catheter for treating paroxysmal atrial fibrillation. These initiatives mark significant progress for Abbott's PFA catheters.

Regulatory approvals are critical in influencing the PFA industry, as they validate the safety and efficacy of these novel devices, paving the way for broader clinical adoption. In recent years, several PFA systems have received CE marking in Europe, allowing them to be marketed and used across the continent. These approvals are often based on positive clinical trial results that demonstrate the benefits of PFA over traditional methods, particularly in terms of reduced procedure times and fewer complications. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, designed for persistent atrial fibrillation and atrial flutter treatment. This makes Medtronic the first company with two FDA-approved pulsed-field ablation (PFA) technologies for AFib. The Sphere-9 catheter offers flexible treatment options with its 9mm lattice tip, complementing the PulseSelect PFA System, which provides a single-shot solution for pulmonary vein isolation.

Global Pulsed Field Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pulsed field ablation market report based on the components, indication, end use, and region.

  • Components Outlook (Revenue, USD Million, 2018 - 2030)
  • Catheters
  • Generators
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Atrial Fibrillation
  • Non-atrial Fibrillation
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Inpatient Facilities
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million; 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Components
    • 1.2.2. Indication
    • 1.2.3. End use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Components outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pulsed Field Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of cardiac arrhythmias
      • 3.2.1.2. Technological advancements in PFA devices
      • 3.2.1.3. Minimally invasive nature of PFA
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs of PFA devices and procedures
      • 3.2.2.2. Lack of long-term data on effectiveness and safety
  • 3.3. Pulsed Field Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pulsed Field Ablation Market: Components Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pulsed Field Ablation Market: Components Movement Analysis
  • 4.3. Pulsed Field Ablation Market by Components Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Catheters
    • 4.5.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Generators
    • 4.6.1. Generators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pulsed Field Ablation Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pulsed Field Ablation Market: Indication Movement Analysis
  • 5.3. Pulsed Field Ablation Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Atrial Fibrillation
    • 5.5.1. Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Non-Atrial Fibrillation
    • 5.6.1. Non-Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pulsed Field Ablation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pulsed Field Ablation Market: End Use Movement Analysis
  • 6.3. Pulsed Field Ablation Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Inpatient Facilities
    • 6.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Outpatient Facilities
    • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pulsed Field Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Boston Scientific Corporation
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbott
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Medtronic
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Biosense Webster, Inc. (Johnson & Johnson Services, Inc)
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Pulse Biosciences, Inc
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Kardium
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Jia Jing Electronic Co., Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Adagio Medical Inc
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. CardioFocus
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Acutus Medical, Inc
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 4 Global pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America pulsed field ablation market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 8 North America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 9 North America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 11 U.S pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 12 U.S pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 14 Canada pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Canada pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 17 Mexico pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Mexico pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 21 Europe pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Europe pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 24 UK pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 25 UK pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 27 Germany pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Germany pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 29 France pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 30 France pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 31 France pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 32 Italy pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 33 Italy pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 36 Spain pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 39 Denmark pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Denmark pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 41 Norway pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 42 Norway pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Norway pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 45 Sweden pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Sweden pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 52 Japan pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Japan pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 55 China pulsed field ablation market, by indication 2018 - 2030 (USD Million)
  • Table 56 China pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 57 India pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 58 India pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 59 India pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 61 Australia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Australia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 64 South Korea pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 67 Thailand pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 71 Latin America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 74 Brazil pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Brazil pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 77 Argentina pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Argentina pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 84 South Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 85 South Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 90 UAE pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 91 UAE pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pulsed field ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Market formulation & validation
  • Fig. 5 Pulsed field ablation market segmentation
  • Fig. 6 Market driver analysis (current & future impact)
  • Fig. 7 Market restraint analysis (current & future impact)
  • Fig. 8 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 9 Porter's five forces analysis
  • Fig. 10 Pulsed field ablation market, components outlook key takeaways (USD Million)
  • Fig. 11 Pulsed field ablation market: components movement analysis (USD Million), 2024 & 2030
  • Fig. 12 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Generators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Pulsed field ablation market, indication outlook key takeaways (USD Million)
  • Fig. 15 Pulsed field ablation market: indication movement analysis (USD Million), 2024 & 2030
  • Fig. 16 Atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Non-atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Pulsed field ablation market, end use outlook key takeaways (USD Million)
  • Fig. 19 Pulsed field ablation market: end use movement analysis (USD Million), 2024 & 2030
  • Fig. 20 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pulsed field ablation market: regional key takeaways (USD Million)
  • Fig. 23 Pulsed field ablation market: regional outlook, 2024 & 2030, USD Million
  • Fig. 24 North America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 US pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Canada pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Spain pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Norway pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 China pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 South Korea pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Middle East and Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UAE pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 List of key emerging company's/indication disruptors/innovators